HOW B Cell KILLERS treat MS

Multiple Sclerosis - B Cell Depleting Medications - Q&AПодробнее

Understanding MS treatment options, The Future MS Landscape including Biosimilars PLUS Visual issuesПодробнее

Dr Maria Teresa Cencioni - B-cells in multiple sclerosis — from targeted depletion ...Подробнее

Health Matters 2022: Using the Immune System to Treat Cancer with Ronald Levy, MDПодробнее

New MS Medication 💊?Подробнее

How does #Ocrevus kill the B-cells in #MS? Will they ever come back? Prof B answers your questions.Подробнее

The Future of Multiple Sclerosis TherapyПодробнее

Risk of B-Cell Depleters Long-Term (Ocrevus, Rituximab, Kesimpta, Briumvi)Подробнее

How Good Is Kesimpta Actually?Подробнее

Should We Still Use Aubagio to Treat Multiple Sclerosis? [2019]Подробнее

An introduction to the immune systemПодробнее

B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment LandscapeПодробнее

MS Research - Where Are We Headed - Ben Thrower, M.D. - August 2016Подробнее

Rituximab, COVID-19 and vaccine readiness in MSПодробнее

Multiple Sclerosis Vlog: COVID-19, OCREVUS and YOUR RISK [3/2020]Подробнее

Should ocrelizumab & cladribine be treated in the same way as alemtuzumab in terms of COVID-19 risk?Подробнее